-+ 0.00%
-+ 0.00%
-+ 0.00%

NXERA PHARMA CO. - $100 MLN UPFRONT PAYMENT EXPECTED TO BE RECOGNIZED AS REVENUE IN Q4 FY2026

Reuters·11/04/2026 08:40:56

Please log in to view news